Comments
Shares of Biocon Ltd fell as much as 7.6 per cent to Rs 346.70 in early trade, its biggest intra-day percentage loss since March 2.
US FDA issued 10 observations pointing at aseptic practices after an inspection at the drugmaker's plant in Bengaluru, media reports said citing a Form 483 issued on the regulator's website
The regulator earlier issued a form 483 with 8 observations in April for the Bengaluru facility
Shares of other Indian drugmakers were also down - Sun Pharmaceutical Industries Ltd was down as much as 4.5 per cent, Cadila Healthcare Ltd lost as much as 2.9 per cent.
Nifty pharma index slipped as much as 2.5 per cent in its biggest intraday pct loss since May 29
Up to Thursday's close, Biocon's stock had risen 18.4 per cent this year.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.